Tools · DCT Cost Model
DCT Cost Model
An order-of-magnitude estimate for what a decentralised trial costs on Vitruvian Shield, against a traditional CRO setup. Inputs reflect publicly documented industry cost ranges; actual quotes are bespoke.
Indicative estimate from internal cost assumptions, available on request; not a quotation.
Vitruvian Shield estimate
€898,200
Traditional CRO estimate
€1,776,000
Estimated saving
€877,800
49% lower than the traditional estimate
Cost assumptions and sources
- Sertkaya A. et al. (2016). Key cost drivers of pharmaceutical clinical trials. Clinical Trials.
- Lo Re V. et al. (2024). Decentralized clinical trials operational cost benchmarks. NEJM Evidence.
- Tufts Center for the Study of Drug Development (2023). Operational cost benchmarks for site activation and per-participant burden.
- Vitruvian Shield commercial pricing (2026). Platform license, EDC integration fees, and academic-program tariff.
- Per-site cost differentials in decentralized vs traditional designs derived from published case data; reduced site burden assumed at the lower bound of the published range.